GLP-1 sales due largely to the persistent use of compounded GLP-1s. Novo Nordisk said the targets of its lawsuits include telehealth companies selling compounded semaglutide under the false guise of personalized medicine. advertisement advertisement However, the company has not sued Hims & Hers, the subject of a very public breakup between the two entities in June, less than three months after the major telehealth player began selling Wegovy, with Novo Nordisk citing deceptive marketing practices as a cause
Its about defending access to medications for hospice patients, children, pet owners, and anyone who relies on customized medicine
Guirguis says combination treatments such as this could offer additive or synergistic effects meaning that patients have a better chance of responding to at least one of the mechanisms and could experience fewer GI side effects as a result of the dual approach
If youre curious about Motus (oral), ask your clinician to review the trial size, inclusion criteria, and adverse event data so you can make an informed choice